A Plan for CMAAO Countries for reducing the incidence of HIV by 75% in 5 years, and by 90% by 2030 has been developed. The key highlights of the plan are:

1. Today, antiretroviral drugs combined in a single pill taken once a day can enable a person living with HIV to achieve a nearly normal lifespan.
2. Antiretrovirals can treat HIV, maintain the health of an individual, and prevent transmission of the virus
3. People living with HIV, and on antiretroviral drugs to achieve and maintain a durably undetectable level of virus, do not transmit HIV. This prevention strategy, is known as Undetectable = Untransmittable, or U=U.
4. Antiretrovirals in pregnant HIV positive can prevent perinatal transmission of the virus.
5. ART is recommended for all HIV-infected pregnant women to decrease the rate of perinatal HIV transmission as well as to treat the mother.
6. For HIV-negative people at risk for HIV, a single pill given daily as pre-exposure prophylaxis, or PrEP, can reduce the risk of acquiring HIV by 99%.
7. Emergency post-exposure prophylaxis, or PEP, can also prevent HIV from becoming established in the body if initiated within three days of exposure and taken for an additional 28 days.
8. NIH continue to pursue the development of a safe and effective vaccine to prevent HIV and a cure for those living with HIV.
9. “Community by Community" approach should be adopted to end the HIV epidemic. 
10. Ensure that hard-to-reach communities; the transgender, black, gay, injection users, and CSW communities — benefit from these strategies.
11. Test and treat policy: ART (potent three drugs combination) is recommended for all HIV-infected individuals regardless of CD4 cell count.

Dr KK Aggarwal

Padma Shri Awardee

President Confederation of Medical Associations in Asia and Oceania (CMAAO)

Group Editor-in-Chief IJCP Publications

President Heart Care Foundation of India

Past National President IMA